The latter.
If true, this seems to be a reasonable and even stellar perk of working there.
How do you know this to be true?
Diagnostics for finding risk factors (i.e., Invitae and GeneDX) and informing treatment for cancer are definitely different things. Foundation Genetic’s stated business model is to deliver diagnostics to inform treatment:
1 Like
We need some sort of low-cost sequencing devices to be available on the commodity market. Kind of like just few years ago laser cutters were an exotic thing few dreamed to own and today you can get a decent (okay, lousy but still pretty usable) one for sub-$1000.
This topic was automatically closed after 5 days. New replies are no longer allowed.
